Remove Article Remove Clinical Trials Remove Data Remove Tincture
article thumbnail

Vice Article: Australians Can Get a Medicinal Cannabis Prescription for Pretty Much Anything

Cannabis Law Report

First academic study of national medicinal cannabis data. This is despite a limited number of high-quality clinical trials investigating the drug’s efficacy for this condition. The authors note, however, that the data doesn’t include patient outcomes. Here’s the Uni of Sydney press release. 11 May 2022.

article thumbnail

How Cannabis Research is Affecting Parkinson’s Disease

The Joint Blog

Numerous trials have been run using medical marijuana and CBD tinctures to treat or reduce the symptoms of Parkinson’s Disease. This is not the first medicinal trial of its kind. The effects were so promising that Parkinson’s UK began funding for the worlds first clinical trial. This trial was to take 3.5

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

What is CBD? Everything you need to know

The Cannigma

Cannabis products such as oils, tinctures and creams are usually decarboxylated as part of their preparation. However, the scientific data on CBG is nowhere near as developed as what we have on CBD. Indeed, the scientific literature regarding CBD and some forms of epilepsy is rich and full of data.

CBD 122
article thumbnail

Curaleaf shares down 8% after FDA sends warning letter over CBD health claims

Cannabis Law Report

FDA has determined that your “CBD Lotion,” “CBD Pain-Relief Patch,” “CBD Tincture,” and “CBD Disposable Vape Pen” products are unapproved new drugs sold in violation of sections 505(a) and 301(d) of the Federal Food, Drug, and Cosmetic Act (the FD&C Act), 21 U.S.C. 355(a) and 331(d). Unapproved New and Misbranded Human Drug Products.

CBD 51
article thumbnail

Meredith Fisher-Corn, MD…….”Are You Able to Answer Your Patients’ Medical Marijuana Questions”

TheAnswerPage

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1).

article thumbnail

CBD Market Report

Project CBD

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Available at: www.ncbi.nlm.nih.gov/pmc/articles/PMC7400098/.

CBD 144
article thumbnail

Best strains and terpenes for migraine relief

The Cannigma

This article includes strain names as a starting point for you to find flower or products near you that match the chemical makeup, not the exact strain name. Russo concluded the evidence he examined “supports experimental protocols of cannabis usage in migraine treatment should go forward employing modern controlled clinical trials.”

Terpenes 132